Skip to content
healthcare.dev

Teriflunomide

NDC 69339-170, Teriflunomide, tablet, from Natco Pharma USA LLC.

Product NDC
69339-170
Status
Listed
Labeler
Natco Pharma USA LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209555
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69339-170 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TERIFLUNOMIDE14 mg/1

Pharmacologic classes

Dihydroorotate Dehydrogenase Inhibitors [MoA]; Pyrimidine Synthesis Inhibitor [EPC]

Package NDCNDC-11Package
69339-170-036933901700330 TABLET in 1 BOTTLE (69339-170-03)
69339-170-096933901700990 TABLET in 1 BOTTLE (69339-170-09)
69339-170-93693390170932 BLISTER PACK in 1 CARTON (69339-170-93) / 30 TABLET in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/8219b4a2-fb9d-4387-ba33-96d28aad71dd

Use it

Look up 69339-170 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69339-170 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69339-170. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.